Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery
Authors:
- 6 August 2021
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 32 (1) , 497-507
Abstract
Objectives The identification of viable tumor after stereotactic radiosurgery (SRS) is important for future targeted therapy. This study aimed to determine whether tumor habitat on structural and physiologic MRI can distinguish viable tumor from radiation necrosis of brain metastases after SRS. Method Multiparametric contrast-enhanced T1- and T2-weighted imaging, apparent diffusion coefficient (ADC), and cerebral blood volume (CBV) were obtained from 52 patients with 69 metastases, showing enlarging enhancing masses after SRS. Voxel-wise clustering identified three structural MRI habitats (enhancing, solid low-enhancing, and nonviable) and three physiologic MRI habitats (hypervascular cellular, hypovascular cellular, and nonviable). Habitat-based predictors for viable tumor or radiation necrosis were identified by logistic regression. Performance was validated using the area under the curve (AUC) of the receiver operating characteristics curve in an independent dataset with 24 patients. Results None of the physiologic MRI habitats was indicative of viable tumor. Viable tumor was predicted by a high-volume fraction of solid low-enhancing habitat (low T2-weighted and low CE-T1-weighted values; odds ratio [OR] 1.74, p <.001) and a low-volume fraction of nonviable tissue habitat (high T2-weighted and low CE-T1-weighted values; OR 0.55, p <.001). Combined structural MRI habitats yielded good discriminatory ability in both development (AUC 0.85, 95% confidence interval [CI]: 0.77–0.94) and validation sets (AUC 0.86, 95% CI:0.70–0.99), outperforming single ADC (AUC 0.64) and CBV (AUC 0.58) values. The site of progression matched with the solid low-enhancing habitat (72%, 8/11). Conclusion Solid low-enhancing and nonviable tissue habitats on structural MRI can help to localize viable tumor in patients with brain metastases after SRS. Key Points • Structural MRI habitats helped to differentiate viable tumor from radiation necrosis. • Solid low-enhancing habitat was most helpful to find viable tumor. • Providing spatial information, the site of progression matched with solid low-enhancing habitat.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1A2B5B01001707, NRF-2020R1A2C4001748)
This publication has 40 references indexed in Scilit:
- A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain MetastasesAmerican Journal of Neuroradiology, 2011
- Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Perfusion CT Imaging of Brain Tumors: An OverviewAmerican Journal of Neuroradiology, 2010
- T1/T2 Matching to Differentiate Tumor Growth From Radiation Effects After Stereotactic RadiosurgeryNeurosurgery, 2010
- Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrenceJournal of Neurology, 2009
- Pathological review of late cerebral radionecrosisBrain Tumor Pathology, 2008
- CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC-PATHOLOGICAL STUDYNeurosurgery, 2008
- Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast‐enhanced magnetic resonance imagingJournal of Magnetic Resonance Imaging, 2005
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988